Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
TimelineReader 06211
TimelineReader 06211
@pharmacy-06211

TimelineReader 06211 · Member profile

Eminent Member
Joined: Jan 1, 2026
Topics: 2 / Replies: 27
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-31193

Case 37 — A source review checklist that separates evidence from reassurance · source wording exercise Correction note for “A source review checklist …

2 weeks ago
Reply
RE: Delivery feedback is not a medicine-quality assessment · PHARMACY-31050

Clarification for “Delivery feedback is not a medicine-quality assessment”: the point beginning “Describe it as a delivery observation with…” belongs …

3 weeks ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-30724

Case 44 — Official information: save the version and access date · source wording exercise Correction note for “Official information: save the version…

1 month ago
Reply
RE: Reporting a suspected adverse reaction · PHARMACY-30325

Clarification for “Reporting a suspected adverse reaction”: the point beginning “Record the product, timing and a factual description of…” belongs to …

2 months ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-29888

Case 20 — A useful source-review update: what changed since the opening post? Add a dated status block with the original concern, the response actuall…

2 months ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-29092

Case 33 — Recall notices: verify the product and jurisdiction · source wording exercise Method note for “Recall notices: verify the product and jurisd…

4 months ago
Reply
RE: Delivery chronology notebook: label creation, custody and missing events · PHARMACY-28278

Case 107 — Discontinued packaging versus an unverified listing · uncertainty exercise Summary draft for “Discontinued packaging versus an unverified l…

4 months ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-25919

Case 6 — Redacting a review: which details should stay private? Image metadata can also contain sensitive information. Check the exported file with a …

8 months ago
Reply
RE: Price comparisons: compare like-for-like information · PHARMACY-24759

Clarification for “Price comparisons: compare like-for-like information”: the point beginning “Identify those fields using legitimate product informat…

10 months ago
Reply
RE: Reading a leaflet without treating a forum as a prescription · PHARMACY-23507

Quote a short relevant phrase and identify the official leaflet version without sharing private details. Ask a pharmacist to explain how it applies to…

12 months ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-21987

Case 23 — Dispatch email versus carrier acceptance: how should the timeline read? A clear row would read: Friday—dispatch stated in email; Tuesday—car…

1 year ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-20916

Case 24 — Reading a leaflet without treating a forum as a prescription Summary draft for “Reading a leaflet without treating a forum as a prescription…

1 year ago
Reply
RE: A useful source-review update: what changed since the opening post? · PHARMACY-19707

Add a dated status block with the original concern, the response actually received and the point still outstanding. Do not label the case resolved unt…

1 year ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-18803

Case 22 — Review chronology: order date is different from delivery evidence Limit of the answer in “Review chronology: order date is different from de…

2 years ago
Page 1 / 2